Rubin speaks about how drugs aren’t being properly valued.
Lakdawalla speaks about how drugs aren’t being properly valued.
Accenture’s global life sciences technology lead discusses how the life sciences industry has embraced artificial intelligence.
Cleve talks about the future of the industry and how data remains a key focus.
Early success ignites promise in reshaping standards of care for HER2 breast cancer.
Embrace the tools that solve real problems and make life easier.